awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q35603660-143ECC3E-5C7B-4E87-958C-A4B79E374C6D
Q35603660-143ECC3E-5C7B-4E87-958C-A4B79E374C6D
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35603660-143ECC3E-5C7B-4E87-958C-A4B79E374C6D
Circulating cell-free AR and CYP17A1 copy number variations may associate with outcome of metastatic castration-resistant prostate cancer patients treated with abiraterone.
P2860
Q35603660-143ECC3E-5C7B-4E87-958C-A4B79E374C6D
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35603660-143ECC3E-5C7B-4E87-958C-A4B79E374C6D
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
ee38382a2e5ae1b54818b1ebeeeb41d37fce48e2
P2860
Enzalutamide in castration-resistant prostate cancer patients progressing after docetaxel and abiraterone.